Vicki L Sato's Net Worth
$66.7 Million
Who is Vicki L Sato?
Vicki L Sato has an estimated net worth of $66.7 Million. This is based on reported shares across multiple companies, which include BRISTOL MYERS SQUIBB CO, ALNYLAM PHARMACEUTICALS, INC., BORGWARNER INC, Allogene Therapeutics, Inc., Denali Therapeutics Inc., Vir Biotechnology, Inc., Syros Pharmaceuticals, Inc., Akouos, Inc., INFINITY PHARMACEUTICALS, INC., VERTEX PHARMACEUTICALS INC / MA, and PERKINELMER INC.
SEC CIK
Vicki L Sato's CIK is 0001197020
Past Insider Trading and Trends
2004 was Vicki L Sato's most active year for acquiring shares with 39 total transactions. Vicki L Sato's most active month to acquire stocks was the month of April. 2004 was Vicki L Sato's most active year for disposing of shares, totalling 88 transactions. Vicki L Sato's most active month to dispose stocks was the month of January. 2022 saw Vicki L Sato paying a total of $341,846.70 for 116,784 shares, this is the most they've acquired in one year. In 2014 Vicki L Sato cashed out on 43,686 shares for a total of $960,349.34, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
BRISTOL MYERS SQUIBB CO (BMY) Snapshot price: $48.645
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 30
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 31
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 31
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 28
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 29
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 30
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 29
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 29
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
ALNYLAM PHARMACEUTICALS, INC. (ALNY) Snapshot price: $168.935
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 11
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 3
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 7
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
BORGWARNER INC (BWA) Snapshot price: $33.845
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +28.38% | 4.38K |
$29.67 | $130,013.94 | 19.82K |
Apr 29
| |||
Form 4
| +24.03% | 2.98K |
$43.55 | $129,996.75 | 15.4K |
Apr 24
| |||
Form 4/A
| +24.77% | 2.46K |
$52.91 | $129,999.87 | 12.38K |
Apr 25
| |||
Form 4
| +24.77% | 2.46K |
$52.91 | $129,999.87 | 12.38K |
Apr 25
| |||
Form 4
| +43.16% | 2.99K |
$41.13 | $123,004.88 | 9.92K |
Apr 26
| |||
Form 4
| +82.42% | 3.13K |
$39.28 | $123,001.34 | 6.93K |
Apr 27
| |||
Form 4
| +99.85% | 1.89K |
$60.95 | $115,003.22 | 3.78K |
Apr 29
| |||
Form 4
|
∞
| 1.87K |
$61.40 | $114,992.84 | 1.87K |
Apr 30
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Allogene Therapeutics, Inc. (ALLO) Snapshot price: $4.11
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +60.81% | 61.48K |
—
|
—
| 162.57K |
Jun 5
| |||
Form 4
| +143.90% | 59.65K |
—
|
—
| 101.1K |
Jun 13
| |||
Form 4
| +114.08% | 22.09K |
—
|
—
| 41.45K |
Jun 15
| |||
Form 4
|
∞
| 19.36K |
—
|
—
| 19.36K |
Jul 30
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Denali Therapeutics Inc. (DNLI) Snapshot price: $16.61
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -2.52% | -3.08K |
$22.14 | -$68,203.60 | 119.26K |
Scheduled
|
Jul 1
| ||
Form 4
| +5.13% | 5.97K |
—
|
—
| 122.34K |
May 31
| |||
Form 4
| -1.42% | -1.67K |
$20.39 | -$34,132.86 | 116.37K |
Scheduled
|
May 15
| ||
Form 4
| -1.39% | -1.67K |
$18.29 | -$30,471.14 | 118.04K |
Scheduled
|
Apr 15
| ||
Form 4
| -1.37% | -1.67K |
$20.10 | -$33,486.60 | 119.71K |
Scheduled
|
Mar 15
| ||
Form 4
| -1.35% | -1.67K |
$18.37 | -$30,604.42 | 121.38K |
Scheduled
|
Feb 15
| ||
Form 4
| -1.34% | -1.67K |
$18.42 | -$30,687.72 | 123.04K |
Scheduled
|
Jan 16
| ||
Form 4
| -1.32% | -1.67K |
$23.39 | -$38,967.74 | 124.71K |
Scheduled
|
Dec 15
| ||
Form 4
| -1.30% | -1.67K |
$19.13 | -$31,870.58 | 126.37K |
Scheduled
|
Nov 15
| ||
Form 4
| -1.28% | -1.67K |
$20.66 | -$34,419.56 | 128.04K |
Scheduled
|
Oct 16
| ||
Form 4
| -1.27% | -1.67K |
$23.62 | -$39,347.60 | 129.71K |
Sep 15
| |||
Form 4
| -1.25% | -1.67K |
$24.30 | -$40,483.80 | 131.37K |
Aug 15
| |||
Form 4
| -1.24% | -1.67K |
$29.60 | -$49,313.60 | 133.04K |
Jul 17
| |||
Form 4
| -1.22% | -1.67K |
$29.84 | -$49,709.32 | 134.7K |
Jun 28
| |||
Form 4
| +3.19% | 4.22K |
—
|
—
| 136.37K |
Jun 1
| |||
Form 4
| +4.40% | 5.99K |
—
|
—
| 142.15K |
Jun 2
| |||
Form 4
| -1.30% | -1.67K |
$52.81 | -$87,982.94 | 126.17K |
Scheduled
|
Nov 10
| ||
Form 4
| -1.29% | -1.67K |
$50.05 | -$83,383.30 | 127.83K |
Scheduled
|
Nov 1
| ||
Form 4
| -1.27% | -1.67K |
$53.40 | -$88,969.48 | 129.5K |
Scheduled
|
Sep 15
| ||
Form 4
| -1.25% | -1.67K |
$51.70 | -$86,138.76 | 131.16K |
Scheduled
|
Aug 18
| ||
Form 4
| -1.24% | -1.67K |
$65.13 | -$108,509.84 | 132.83K |
Scheduled
|
Jul 21
| ||
Form 4
| -1.22% | -1.67K |
$70.74 | -$117,844.85 | 134.5K |
Scheduled
|
Jun 23
| ||
Form 4
| +1.55% | 2.07K |
—
|
—
| 136.16K |
Jun 2
| |||
Form 4
| -1.23% | -1.67K |
$65.37 | -$108,911.49 | 134.09K |
Scheduled
|
May 26
| ||
Form 4
| -1.21% | -1.67K |
$62.15 | -$103,538.44 | 135.75K |
Scheduled
|
Apr 28
| ||
Form 4
| -1.20% | -1.67K |
$56.42 | -$93,992.04 | 137.42K |
Scheduled
|
Mar 31
| ||
Form 4
| -1.18% | -1.67K |
$61.61 | -$102,640.91 | 139.09K |
Scheduled
|
Mar 3
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 3
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 30
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 13
| |||
Form 4
| +83.33% | 62.5K |
—
|
—
| 137.5K |
Dec 12
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 7
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||